Sort   by:  
 Page size 
UnknownFc-GDF15 glyco-engineering and receptor binding affinity optimization for body weight regulation.
Not available
S-EPMC8076310 | biostudies-literature
ProteomicsFinding the Sweet Spot in ERLIC Mobile Phase for Simultaneous Enrichment of N-Glyco and Phosphopeptides
Simultaneous enrichment of glyco- and phospho- peptides will benefit the studies of biological processes regulated by these post-translational modifications (PTMs). It will also reveal potential crosstalk between these two ubiquitous PTMs. Unlike custom designed multifunctional solid phase extractio...
ORGANISM(S): Homo sapiens (Human) 
2019-09-06 | PXD015179 | Pride
Mm.1s Glycosylation Erlic Phosphorylation Lc-ms/ms 
UnknownGlyco-Engineered Anti-Human Programmed Death-Ligand 1 Antibody Mediates Stronger CD8 T Cell Activation Than Its Normal Glycosylated and Non-Glycosylated Counterparts.
Not available
S-EPMC6054930 | biostudies-literature
UnknownModulating Cytotoxic Effector Functions by Fc Engineering to Improve Cancer Therapy.
Not available
S-EPMC5649276 | biostudies-literature
UnknownIncreasing FcγRIIa affinity of an FcγRIII-optimized anti-EGFR antibody restores neutrophil-mediated cytotoxicity.
Not available
S-EPMC3984330 | biostudies-literature
UnknownGlyco-engineered Long Acting FGF21 Variant with Optimal Pharmaceutical and Pharmacokinetic Properties to Enable Weekly to Twice Monthly Subcutaneous Dosing.
Not available
S-EPMC5844872 | biostudies-literature
UnknownPlant-produced SARS-CoV-2 antibody engineered towards enhanced potency and in vivo efficacy.
Not available
S-EPMC11672753 | biostudies-literature
ProteomicsGlycomics and Glycoproteomics Reveal Distinct Oligomannose Carriers Across Bladder Cancer Stages
Aberrant glycosylation is a hallmark of cancer, offering opportunities to enhance clinical decision-making and enable precise targeting of cancer cells. Nevertheless, alterations in the bladder urothelial carcinoma (BLCA) N-glycome remain poorly characterized. Here, we used in situ N-deglycosylation...
ORGANISM(S): Homo sapiens (Human) 
2025-05-20 | PXD063671 | Pride
Bladder cancer  n-glycomics  n-glycoproteins 
UnknownAsymmetric <i>N</i>-Glycosylation in the Tailpiece of Recombinant IgA1.
Not available
S-EPMC11664498 | biostudies-literature
ProteomicsRe-analysis of glycoproteomics data with MSFragger-Glyco
Reanalysis of submissions PXD011533 and PXD009476 using MSFragger-Glyco mode. Processed MSFragger results files (pepXML) and PSM tables (psm.tsv) supporting MSFragger-Glyco manuscript (Fast and Comprehensive N- and O-glycoproteomics analysis with MSFragger-Glyco. Recent advances in methods for enric...
ORGANISM(S): Mus musculus (Mouse) Homo sapiens (Human) 
2020-10-06 | PXD021196 | Pride
Glycosylation Glycoproteomics Msfragger Reanalysis O-glycosylation Glycan Glycopeptide N-glycosylation 
Sort   by:  
 Page size